The Belgian-based pharmaceutical company, Glaxo-Smith-Kline, has introduced a new vaccine to prevent six child-hood diseases. The vaccine ‘the first of its kind in South Africa – is aimed at protecting children against whoopping cough, polio, diphtheria, tetanus, hepatitis B and haemophilus influenza type B.
HIV and AIDS HIV Treatment Public Health & Health Systems Science; Research & Innovations Vaccines
A first in HIV vaccine trials is taking place in South Africa. A vaccine will be tested on people already infected with the HI-virus in the hope that it will delay or prevent their progression to full-blown AIDS.
Temperatures are dropping and leaves are turning. Winter is on its way and that means the flu is not far behind. Influenza can be fatal for some, including those living with HIV.
The second HIV prevention vaccine to be tested in South Africa began its Phase One trial in Johannesburg and Durban, on Wednesday November 11, 2003. The testing of the Modified Vaccinia Ankara (MVA) follows just a week after the start of the Venezuelan Equine Encephalitis vaccine trial. Dr Eftyhia Vardas, Director of the HIV Vaccines […]
The Phase One trial for the Modified Vaccinia Ankara (MVA) vaccine is now underway. Two of the first 55 volunteers in South Africa ‘ 40 in Soweto and 15 in Durban – have received their initial vaccinations. Worldwide a total of 111 people are taking part at research sites in Switzerland, the UK and The […]
Talita Thekiso is one of two volunteers who received her first dose of the Modified Vaccinia Ankara (MVA) vaccine at Chris Hani Baragwanath Hospital, in Soweto on Wednesday. The MVA vaccine is based on sub-type A of HIV, a strain of the virus which is predominant in east Africa. Health-e met Thekiso at the hospital.